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Abstract 
Background: Functional Neurological Symptoms (FNS) are 
considered non-volitional and potentially highly disabling, but 
are not explainable by neurological disease or structural 
abnormalities. Brief Augmented Psychodynamic Interpersonal 
Therapy (BAPIT), was adapted to treat the putative emotion 
processing deficits thought to be central to FNS aetiology and 
maintenance. BAPIT for FNS has previously been shown to 
improve levels of distress and functioning, but it is unknown 
whether improvements on such measures correlate with 
improvements in emotion processing - which this treatment 
focuses on.  
Aim: To determine a) whether the recently developed 
Emotional Processing Scale-25 can be used to demonstrate 
BAPIT-associated changes in patients with FNS, and b) 
whether changes in the EPS-25 are associated with changes in 
previously validated outcome measures. 
Method: 44 patients with FNS completed questionnaires 
including the EPS-25 and measures of clinical symptomology 
(health-related quality of life (SF-36), somatic symptoms 
(PHQ-15), psychological distress (CORE-10), illness 
understanding (BIPQ)) pre- and post-therapy.  
Results: Emotion processing improved following therapy (p = 
.049). Some measures of clinical symptomology also improved, 
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namely health-related quality of life (p = 0.02) and illness 
understanding (p = 0.01). Improvements in the EPS-25 
correlated with improvements in mental health-related quality 
of life and psychological distress. 
Conclusions: Emotion processing and some measures of 
clinical symptomology improved in patients with FNS 
following BAPIT. The EPS-25 demonstrated changes which 
correlated with previously validated outcome measures and 
should therefore be suitable as a measure of psychotherapy-
associated change in the FNS patient population. 
Keywords: Functional Neurological Symptoms, Emotion 
processing, Psychopathology, Quality of life 
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Changes in emotion processing following Brief Augmented 
Psychodynamic Interpersonal Therapy for Functional 
Neurological Symptoms 
 
Functional Neurological Symptoms (FNS) are 
manifestations of altered motor or sensory functions not caused 
by readily identifiable structural or pathophysiological changes 
in the nervous system (Carson et al., 2012). The DSM-V refers 
to FNS as ‘Conversion Disorder’ (American Psychiatric 
Association, 2013) and the ICD-10 as ‘Somatoform Disorder’ 
(World Health Organization, 2016). In both nosologies FNS 
should not be better explained by other known diagnoses. FNS 
may present as movement disorders, including weakness and 
tremor. FNS may also affect sensory processing and include 
symptoms such as anaesthesia or visual deficits. Nonepileptic 
Attack Disorder (NEAD), is a paroxysmal FNS involving 
episodes of altered consciousness. Approximately one third of 
neurology outpatients present with FNS (Stone, 2013). The 
long-term prognosis is variable but often poor, as FNS are 
associated with as much or more significant disability, distress, 
and unemployment as other “medically explained” conditions 
presenting to neurologists (Carson et al., 2011).  
 The existing categorization of FNS as a ‘Conversion 
Disorder’ reflects the on-going assumption that psychological 
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difficulties may contribute to their aetiology (American 
Psychiatric Association, 2013). Indeed, an interaction between 
pre-disposing, precipitating, and perpetuating factors linked to 
abnormal emotion processing has been proposed as mechanistic 
in FNS aetiology (Carson et al., 2012). ‘Emotion processing’ 
describes the process by which, “emotional disturbances are 
absorbed, and decline to the extent that other experiences and 
behaviours can proceed without disruption.” (p.51) (Rachman, 
1980). According to this model, abnormal emotion processing 
occurs when emotional disturbances are not satisfactorily 
absorbed by an individual. Disrupted emotion processing may 
be evident through direct signs, including intrusive thoughts, 
irritability, or inappropriate expressions of emotion. Rachman 
argues that there are also ‘indirect’ signs of unsatisfactory 
emotion processing, including fatigue, insomnia, and anorexia 
(Rachman, 1980).  Abnormal emotion processing theoretically 
contributes to the symptomatology of multiple mental health 
difficulties and personality disorders, including anxiety and 
emotionally unstable (borderline) personality disorder (Kret & 
Ploeger, 2015).  
Emotion processing is a multi-faceted concept; 
consequently there are multiple instruments measuring different 
aspects of emotion processing, such as the Difficulties in 
Emotion Regulation Scale (Gratz & Roemer, 2004) and the 
Toronto Alexithymia Scale (Bagby, 1994). The Emotional 
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Processing Scale (EPS-38)(Baker, Thomas, Thomas, & Owens, 
2007) was developed to create one unified, psychometrically 
sound measurement of emotion processing (Baker et al., 2007). 
It has been used to demonstrate improvements in emotion 
processing and sensitivity to changes in alexithymia as well as 
psychiatric symptom severity following Cognitive Behavioural 
Therapy (Baker et al., 2012).  The Emotional Processing Scale 
(EPS-25) (Baker, Thomas, Thomas, Santonastaso, & Corrigan, 
2015) was later created as a shortened version of the EPS-38, 
with subscales measuring five key variants of abnormal 
emotion processing; namely suppression, signs of unprocessed 
emotion, unregulated emotion, avoidance, and impoverished 
emotional experience.  
Several self-report and experimental studies have 
provided evidence of abnormal emotion processing in patients 
with FNS. This research has primarily focused on NEAD 
(Roberts & Reuber, 2014). In a study by Novakova et al. 
(Novakova, Howlett, Baker, & Reuber, 2015) patients with 
NEAD exhibited greater impairments in emotion processing on 
the EPS-25 than healthy controls. Impairments in emotion 
processing correlated with more severe somatic symptoms, 
greater psychological distress, and a poorer illness 
understanding.  Another study demonstrated that patients with 
NEAD have greater difficulty in describing and identifying 
their emotions as well as possessing more negative beliefs 
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about emotions than healthy controls (Urbanek, Harvey, 
McGowan, & Agrawal, 2014). Abnormal attentional biases to 
emotional information and altered physiological markers of 
autonomic arousal are also evident in this population (Bakvis et 
al., 2009). Likewise, disrupted emotion processing is evident in 
patients with functional motor symptoms. Using event-related 
fMRI, Aybek et al. demonstrated an increased amygdala 
response amplitude to fearful imagery, suggesting altered 
emotion regulation (Aybek et al., 2015). Furthermore, patients 
with such symptoms have greater difficulty in identifying and 
describing emotions than controls (Demartini et al., 2014). 
Patients with functional motor symptoms also have lower 
interoceptive accuracy than healthy controls, elucidating a 
mechanism by which difficulties in emotion identification and 
processing could manifest (Ricciardi et al., 2015). Given the 
multiple forms of emotion processing impairments that have 
been identified in the FNS population, the administration of a 
single questionnaire in clinical or research settings may 
therefore be an efficient approach to capturing the range of 
emotional difficulties in this population.  
The putative links between abnormal emotion 
processing and FNS suggest that patients could benefit from 
psychotherapeutic interventions aiming to improve emotion 
processing. Indeed, there is some evidence that Psychodynamic 
Interpersonal Therapy (PIT) can help patients with FNS; a brief 
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course of PIT was effective in a randomised control trial of 
patients with ‘multisomatoform disorder’ which included at 
least one FNS (Sattel et al., 2012). Brief Augmented 
Psychodynamic Interpersonal Therapy (BAPIT), is an 
augmented version of traditional PIT, with elements of somatic 
trauma therapy. BAPIT was adapted specifically to address 
FNS (Howlett & Reuber, 2009; Sattel et al., 2012) and assumes 
that psychological difficulties result from interpersonal 
conflicts in early life.  Deep-rooted and commonly occurring 
issues in this population, such as childhood trauma or neglect 
are addressed (Reuber, Howlett, Khan, & Grunewald, 2007). 
The therapeutic targets of BAPIT include deficits in emotion 
processing (including the naming, tolerance, and expression of 
emotions) thought to play a role in FNS aetiology. BAPIT has 
been associated with significant improvements in psychological 
distress, mental health, physical health, and healthcare 
utilization in patients with FNS (Reuber, Burness, Howlett, 
Brazier, & Grunewald, 2007).  In patients with NEAD, BAPIT 
has also been associated with sustained improvements in 
seizure control and healthcare utilisation (Mayor, Howlett, 
Grunewald, & Reuber, 2010). However, whilst BAPIT aims to 
improve emotion processing, it has not yet been examined 
whether the treatment-associated improvements in outcome 
measures are associated with similar improvements in emotion 
processing. What is more, the EPS-25 is a novel questionnaire, 
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and it has not yet been demonstrated whether it is sensitive to 
therapy-associated changes in emotion processing in the FNS 
population.  
The aim of the present study was therefore to explore 
whether emotion processing as measured by the EPS-25 
improved following a course of BAPIT.  We also aimed to see 
whether changes seen in health-related quality of life (HRQoL) 
and some measures of relevant clinical symptomology 
(psychological distress, illness understanding, and somatic 
symptoms) correlated with changes in the EPS-25 scores. 
Finally, we aimed to see whether EPS-25 change scores were 
sensitive to changes in the measures of clinical symptomology 
used in this study. Given the theorised causal links between 
abnormal emotion processing and FNS, we predicted that 
patients would experience therapy-associated improvements in 
emotion processing, HRQoL, and clinical symptomology. We 
also predicted that changes in EPS-25 scores would correlate 
with changes in measures of HRQoL and measures of clinical 
symptomology.  
Methods 
Regulatory approvals 
This study was granted ethical approval by the Sheffield 
Local Research Ethics Committee (REC 09/H1308/2; 
01/05/2009). Research governance approval was given by the 
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research departments of the Sheffield Teaching Hospitals 
Foundation Trust and the Barnsley Hospital NHS Foundation 
Trust. 
Participants 
 Patients with FNS were recruited consecutively from 
referrals to Neurology Psychotherapy Services at the Barnsley 
Hospital and the Royal Hallamshire Hospital. The FNS 
diagnosis was formulated by Consultant Neurologists on the 
basis of all available clinical information. Neurologists were 
sufficiently certain about this diagnosis to recommend 
psychological treatment and withdraw treatment for alternative 
neurological diagnoses (e.g. antiepileptic drugs). All patients 
provided written informed consent. 
Treatment 
 BAPIT is based on an adapted version of PIT (Hobson, 
1985), which assumes that dysfunctional interpersonal patterns 
originating from childhood are mechanistic in the development 
of abnormal emotion processing. We have described this 
approach in greater detail elsewhere (Howlett & Reuber, 2009). 
BAPIT is intended to improve emotion processing, increase 
symptom control, change illness perceptions, and improve 
quality of life through increasing independence and 
encouraging self-care.  In view of the heterogeneous pre-
disposing, precipitating, and perpetuating factors contributing 
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to the aetiology of FNS, BAPIT is based on a personalised 
assessment of each patient and can also include elements 
traditionally associated with Cognitive Behavioural Therapy 
such as goal-setting, exposure, and relaxation. If the patient has 
problems with hyper- or hypo-arousal (often occurring in the 
context of a trauma history), elements of Somatic Trauma 
Therapy, designed to allow patients to control autonomic 
arousal, identify personal triggers, and process traumatic 
memories, are incorporated (Rothschild, 2000). Help from 
carers may be recruited if appropriate (Howlett & Reuber, 
2009). 
In practice, therapists employ ‘here and now’ 
techniques to help the patient notice, tolerate, and understand 
emotions arising in the session. The patient is encouraged to 
stay with emotions as they manifest, notice their location in the 
body, and describe what they feel as a way of linking the 
emotion to associated physical symptoms / sensations e.g., “I 
wonder where you can feel that anger in your body right now?” 
Linking hypotheses are used to connect between current and 
other feelings both inside and outside the therapy room e.g., 
“You say you’re feeling angry and frustrated now. I wonder if 
that’s a bit like you used to feel as a child when that teacher 
showed you up in front of the class?” 
A single psychotherapist delivered therapy. 
Psychotherapy duration was tailored to the patients’ needs but 
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was intended to be brief (with a notional maximum number of 
20 sessions). The initial session lasted two hours. All remaining 
sessions lasted 50 minutes. Progress was reviewed after six-
eight sessions. Further sessions were offered if the patient was 
considered to have engaged with therapy and if there was a 
therapeutic need for further sessions agreed upon by both the 
patient and the therapist. The end of therapy was agreed upon 
between the two parties when the 20-session limit was reached 
or when both parties agreed that therapy was complete (in four 
cases, the therapy was extended beyond 20 sessions because of 
individual patients’ particular needs and circumstances). 
Design and procedure 
This was a prospective, uncontrolled study with a 
within-subjects design. Study information was sent to patients 
along with their first psychotherapy assessment appointment 
letter. FNS diagnosis was re-explained at assessment. Patients 
were screened for factors suggesting they should be excluded 
from outpatient psychotherapy at this point (including risk of 
suicide, serious psychiatric conditions or current addictions). 
Patients were then given a range of symptom-appropriate self-
help strategies, a relaxation CD, and self-help literature. 
Patients were telephoned to check whether their symptoms 
persisted and to arrange regular therapy sessions two months 
from assessment. Pre-intervention questionnaires were posted 
along with the appointment letter to those who agreed to further 
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sessions. Patients were asked to return the questionnaire battery 
in a pre-paid envelope.  Patients failing to do so were given an 
opportunity to complete the pre-intervention questionnaires 
immediately before the first therapy session. The first therapy 
session took place approximately three months after the initial 
assessment visit. 
 Immediately after discharge (either planned or 
following a failure to attend and contact), participants were sent 
a post-intervention self-report questionnaire battery to complete 
and return using a pre-paid envelope. To reduce attrition, 
participants were mailed another copy of the questionnaires if 
they had failed to return the initial post-intervention 
questionnaires. Pre- and post-intervention data were collected 
by an assistant who had not been involved in the administration 
of psychotherapy. Patients who did not complete and return the 
post-intervention questionnaire pack were classified as ‘study 
non-completers’ and excluded from the analysis. 
Measures 
Demographic, referral and psychotherapy 
questionnaires. 
Demographic and clinical information was provided by 
patients, referring neurologists, and the psychotherapist. 
Information regarding the FNS diagnosis was provided by the 
neurologist. Personal information was provided by the 
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participant. An ‘end of therapy summary’ including 
information about the number of sessions, reason for the end of 
therapy, and the issues tackled in therapy was provided by the 
psychotherapist.  
The Emotional Processing Scale (EPS-25). 
The EPS-25 is a standardised 25-item self-report scale 
measuring emotion processing styles and deficits. There are 
five subscales: suppression, signs of unprocessed emotions, 
unregulated emotion, avoidance, and impoverished emotional 
experience (Baker et al., 2009). The EPS-25 has been used in 
patients with lower back pain (Esteves, Wheatley, Mayall, & 
Abbey, 2013), Post-Traumatic Stress Disorder (Compare et al., 
2012), and patients with NEAD (Novakova et al., 2015) but not 
in a sample of patients with mixed FNS. Responses are given 
on a 0-9 Likert scale. There are also three open-ended 
questions. Higher scores indicate greater difficulties with 
emotion processing. As per the administrator’s manual, single 
missing items were replaced by the mean of the subscale 
(Baker et al., 2015).   
The Short Form- 36 (SF-36). 
The SF-36 is a standardised 36-item self-report 
questionnaire that measures nine areas of Health Related 
Quality of Life (HRQoL): physical functioning, role limitation 
- physical, role limitation - emotional, general health, mental 
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health, bodily pain, vitality, health transition, and social 
functioning. Responses are given on scales ranging from three 
to ten options. Higher scores indicate a better HRQoL. Missing 
items were dealt with as recommended by the user manual 
(Ware, Kosinski, & Gandek, 2000). Remaining scores were 
recoded and standardised using norm-based scoring. Scores 
were combined into physical (PHS) and mental health (MHS) 
summary scales, as per the procedure detailed in the manual.  
Clinical Outcome in Routine Evaluations (CORE-10). 
 The CORE-10, is a standardised ten-item self-report 
scale measuring global psychological distress, taken from the 
34 item CORE-OM (Outcome Measure)(Connell & Barkham, 
2007). It has been used in studies of patients with FNS (Reuber, 
Burness, et al., 2007). On a Likert scale (0-4), higher responses 
indicate a higher level of psychological distress experienced 
over the last week. The CORE-10 is known to correlate 
strongly with the Beck Depression Inventory (Beck, Erbaugh, 
Ward, Mock, & Mendelsohn, 1961; Connell & Barkham, 
2007).   
Patient Health Questionnaires (PHQ-15). 
 The PHQ-15 is a standardised 15-item self-report 
questionnaire designed to measure common somatic symptoms, 
e.g. stomach pain or trouble sleeping (Kroenke, Spitzer, & 
Williams, 2002). Participants indicate how bothered they have 
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been by a symptom over the past week, on a three-point Likert 
scale.  Higher scores indicate that participants have been 
bothered more by a particular symptom. A pattern of missing 
items emerged, whereby items 4 and 11 were not responded to 
by 14 and 8 participants respectively. These items may not 
have been relevant to the participants and so were dropped 
from the analysis, replicating the procedure adopted in a 
previous paper (Novakova et al., 2015).  
Brief Illness Perception Questionnaire (BIPQ). 
 The BIPQ is a standardised nine-item self-report scale 
measuring emotional and cognitive representations of illness 
(Broadbent, Petrie, Main, & Weinman, 2006). For eight items, 
participants respond on a 0-10 Likert Scale. The 9th item is an 
open-ended question. The items represent nine dimensions of 
illness perception including consequences, personal control, 
treatment control, timeline, illness concern, coherence, identity, 
emotional representation, and causation. Responses were 
scored and missing items were dealt with as per the scoring 
instructions. 
Statistical analysis 
 Data were analysed using SPSS Version 22.0 (IBM 
Corp, 2013). Prior to the use of inferential statistics, all scales 
scores were screened for normality. The EPS-25 and SF-36 
scale scores were non-normally distributed. Therefore, all 
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analyses of scale scores were bootstrapped using 95% 
confidence intervals based on 1000 samples to control for non-
normality. The p value was set at p = 0.05 (two-tailed 
hypothesis). Otherwise, the inflated risk of Type 1 error 
associated with multiple comparisons was controlled for using 
the Holm-Bonferroni method to correct p values when more 
than one comparison or correlation was being made. 
Repeated measures ANOVAs with Bonferroni 
corrections were used to compare group mean scores on the 
EPS-25 and SF-36 self-report scales pre- versus post-
intervention. The ANOVA model is robust to violations of 
normality when group sizes are equal, as is the case in the 
present study (Field, 2013).  Change scores were calculated 
such that positive values corresponded to improvements in 
functioning across all scales. Pearson’s product moment 
correlation coefficients were used to calculate the relationship 
between change scores on the EPS-25 and the other clinical 
variables. Partial correlation coefficients were used to explain 
the amount of variance shared between EPS-25 change scores 
and any significantly correlated clinical symptomology / 
HRQoL scores. 
3.2. Internal consistency of the Emotion Processing Scale- 25 
 Responses on the EPS-25 were combined into total 
scores for pre- and post-intervention and assessed for internal 
consistency reliability. Internal consistency was excellent when 
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administered both before (α = .962) and after (α = .967) 
intervention.  
 
 
Results 
Patient characteristics 
One hundred and eighteen patients consented to the 
study. Of this group, 72 returned the pre- and 44 also the post-
intervention questionnaire (Figure 1). The final sample 
therefore consisted of 44 patients. 77.3% (34) were female and 
the mean age was 41.5 years (SD = 13.5). 63% of the sample 
were economically inactive (defined as unemployed, in receipt 
of disability benefits, or being retired due to ill-health or old 
age). Mean symptom duration was 5.4 years (SD = 10.8).   The 
mean time between completion of the pre- and post-
intervention questionnaires was 11.0 months. 
 Patients had different main FNS. To explore the 
justification of analysing patients with different FNS together, 
we divided the total group into two subgroups (NEAD and 
‘other FNS’). We compared these two groups on key 
demographic and therapy variables. There were no differences 
between the two groups on the mean number of sessions they 
completed, the number who completed therapy, economic 
activity, gender, and age at the start of therapy (Supplementary 
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Table 1). Mean pre-intervention total EPS-25 scores did not 
differ between these FNS groups; t(42) = .11, p = .91, 95% CI 
[-1.17, 1.49].  
The patient sample also included those who had 
completed therapy in the judgement of the therapist (n = 26) 
and those who had not (n = 17). Reasons for non-completion of 
therapy included therapy was non-appropriate (n = 2), the 
patient was not progressing (n = 2), the patient improved after 
the initial session (n = 1), the patient dropped out (n = 9), and 
‘other’ (n = 2). To explore the justification of including both 
patients who completed therapy and those who did not in the 
analysis, both groups of patients were compared on baseline 
emotion processing and clinical symptomology (Supplementary 
Table 2). There were no differences between the two groups on 
any of these measures.  
 On the basis that the remaining 44 patients with FNS 
did not differ significantly on baseline measures of emotion 
processing and clinical symptomology, irrespective of FNS 
semiology or therapy completion, we analysed the group as a 
whole. 
[FIGURE 1] 
Treatment-associated changes in emotion processing 
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Patients’ pre-intervention EPS-25 scores indicated 
levels of emotion processing problems above normative healthy 
values for the UK, with the mean total EPS-25 scores of the 
FNS sample falling within the top 25th percentile of normative 
values, and well within pain and mental health norms (M = 
4.96, SD = 2.26) (Baker et al., 2015). This indicates that 
emotion processing problems were common in this patient 
group before the intervention.  
The EPS-25 total score and subscale scores were lower 
post-intervention (Table 1). A two-way repeated measures 
ANOVA with time point (pre- and post-intervention) and EPS-
25 subscale (suppression, unprocessed emotion, unregulated 
emotion, avoidance, and impoverished emotional experience) 
as the within-subjects factors showed that there was a 
significant main effect of time point; F(1,43) = 4.09, p = .049, 
 = 0.09, indicating that emotion processing improved 
significantly post-intervention. There was also a significant 
main effect of subscale; F(4,172) = 10.13, p  < .001, =0.19, 
suggesting that the mean scores on each subscale differed from 
each other both pre- and post-intervention. There was no 
significant interaction between time point and subscale, 
indicating that the relationship between the mean subscale 
scores did not vary over time; F(4,172) = 0.923,  p = 0.45, = 
2
p
η
2
p
η
2
p
η
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0.02. Therefore, as measured by the EPS-25, emotion 
processing improved following BAPIT. 
[TABLE 1] 
Treatment-associated changes in routine outcome measures 
HRQoL improved following intervention. The post-
intervention PHS score (M = 38.10, SD = 11.95) was greater 
than the pre-intervention PHS score (M = 36.24, SD = 11.45). 
Likewise, the post-intervention MHS score (M = 42.31, SD = 
11.12) was greater than the pre-intervention MHS score (M = 
40.10, SD = 10.11). A two-way repeated measures ANOVA 
conducted on the SF-36 summary scales (PHS and MHS) with 
time point (pre- and post-intervention) as the within-subjects 
factors showed a significant main effect of time point, 
indicating that SF-36 scores were significantly higher (better 
quality of life) for both the MHS and PHS scores post-
intervention; F(1,38) =  5.94, p = .02,  = 0.14. There was no 
significant main effect of SF-36 summary scale; F(1,38) = 
2.69, p = 0.11,  = 0.07. There was no significant interaction 
effect; F(1,38)  = .018,  p = 0.89, = .00.  
Post-intervention BIPQ scores (M = 48.83, SD = 15.79) 
were lower than pre-intervention scores (M = 55.51, SD = 
11.84). This improvement in illness understanding was 
significant; t(32) = 2.95, p = .01, 95% CI [2.57, 12.39]. While 
2
p
η
2
p
η
2
p
η
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CORE-10 scores were also lower post-intervention (M = 17.05, 
SD = 10.43) than pre-intervention (M = 19.19, SD = 9.39), this 
reduction in psychological distress was not statistically 
significant; t(42) = 1.54, p = 0.13, 95% CI [-.69, 4.76]. 
Similarly, while PHQ-15 scores were lower post-intervention 
(M = 12.14, SD = 6.32) than pre-intervention (M = 14.05, SD = 
5.35), reductions in the number and severity of somatic 
symptoms only approached significance following Holm-
Bonferroni correction; t(36) = 0.2.31, p = 0.03, 95% CI [.35, 
3.43]. 
Did treatment-associated changes on the EPS-25 correlate 
with changes in treatment outcome measures?  
 To assess whether the EPS-25 was sensitive to the 
measures of clinical symptomology and HRQoL of life used in 
this study, a series of correlational analyses were conducted on 
the scale change scores (Table 2). There were moderate to 
strong positive correlations between EPS-25 change scores, 
CORE-10, and MHS scale change scores. However, there were 
no significant correlations between EPS-25 change scores, 
PHQ-15 scores, BIPQ scores or PHS change scores. This 
suggests that improvements in emotion processing were 
associated with improvements in psychological distress and 
mental HRQoL, but not with a better understanding of 
symptoms, fewer somatic symptoms or improved physical 
HRQoL.  
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[TABLE 2] 
Partial correlation coefficients were calculated to 
elucidate the relationship between the CORE-10 / MHS total 
scores and the EPS-25 total score when either CORE-10 or 
MHS-specific variance was controlled for. After controlling for 
the MHS total difference score, the correlation between the 
EPS-25 total difference score and the CORE-10 total difference 
score was smaller, and the amount of shared variance 
decreased, but the correlation was still statistically significant 
[partial correlation = .57, r2 = .32, p < .001, 95% CI [.23, .83]]. 
Similarly, when controlling for the change in MHS scores, the 
correlation between the EPS-25 total difference scores and the 
CORE–10 total difference score was reduced, and the amount 
of shared variance reduced, but the correlation remained 
significant [partial correlation = .56, r2 = .31, p < .001, 95% CI 
[.31, .84]]. These results indicate that EPS-25 change scores 
accounted for 45% and 40% of variance in CORE-10 and MHS 
change scores respectively. 
Study non-completers 
Seventy-four patients consented for the intervention did 
not provide complete follow-up data (Figure 1). Therefore, to 
examine whether attrition biased the results as far as possible, 
study completers were compared against study non-completers 
on a series of key variables.  There were no associations 
between whether a patient completed the study and the 
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demographic variables of gender, economic activity, and FNS 
type. However, study non-completers were younger (M = 34.2 
years, SD = 11.6) than study completers (M = 41.4 years, SD = 
13.5); t(75) = 2.48, p = .02, 95% CI [-12.96, -1.87]. Study non-
completers were also less likely to complete therapy (38.2% 
completed therapy, 61.8% did not complete therapy) in the 
judgement of the therapist; χ2(1) = 5.91, p = .02. However, the 
absence of clear differences between study completers and non-
completers in terms of emotion processing and other baseline 
measures suggests that study completers were representative of 
the total consented sample on the available psychological 
parameters (Table 3).  
[TABLE 3] 
Discussion 
Abnormal emotion processing is an important target for 
psychotherapy in patients with FNS because it may contribute 
to FNS aetiology (Novakova et al., 2015), and appears to be 
related to a poorer quality of life and understanding of the 
disorder (Baker et al., 2007). Therefore, the aim of this study 
was investigate whether emotion processing improved in 
patients with FNS following a course of BAPIT. We also 
explored the extent to which changes in emotion processing 
correlated with treatment-associated changes in HRQoL and 
other measures of clinical symptomology.  
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As predicted, emotion processing improved post-
intervention, accompanied by improved HRQoL and illness 
understanding. Although psychological distress and other 
somatic symptoms failed to improve significantly, change 
scores on the EPS-25 correlated positively with change scores 
on the CORE-10 and MHS sharing 45% and 40% of variance 
respectively. This suggests that improvements captured by the 
EPS-25 are not simply of academic interest but clinically 
meaningful to patients.  
 To our knowledge this the first study to examine 
therapy-associated changes in emotion processing in patients 
with FNS. The significant improvement in HRQoL observed in 
our patient group is consistent with our previous observations 
in this patient population (Reuber, Burness, et al., 2007). 
However, this time we did not observe significant 
improvements in somatic symptoms or psychological distress. 
This discrepancy could be due to the smaller sample size in the 
present study reducing statistical power. Illness understanding 
was not measured in the previous study but we did observe a 
significant improvement in the present patient cohort. One 
earlier study in a much larger sample showed that having a 
poor illness understanding of FNS as measured by the Illness 
Beliefs Questionnaire (including a non-attribution of functional 
symptoms to psychological factors), is a strong predictor of 
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poor patient outcome on a ‘Clinical Global Improvement Scale’ 
at twelve month follow-up (Sharpe et al., 2010).  
The present pre-intervention EPS-25 scores support 
previous observations that many patients with FNS experience 
abnormal emotion processing. Group mean pre-intervention 
total EPS-25 scores fell within the top 25th percentile for UK 
normative values and well within the range for mental health 
patients (Baker et al., 2007). When administered to patients 
with NEAD only, Novakova et al. observed similar 
abnormalities in emotion processing (Novakova et al., 2015). 
Here we extend this finding to include patients with other forms 
of FNS including functional motor and sensory symptoms.  
The breadth of emotion processing styles assessed by 
the EPS-25 is a strength of this study.  It could be argued that 
other forms of emotion processing measurement fail to reflect 
the multi-faceted nature of emotion perception, regulation, and 
expression (Baker et al., 2007). Therefore, the EPS-25 is likely 
to be well-suited to detecting the heterogeneous abnormalities 
of emotion processing which other studies have found to be 
associated with FNS (Carson et al., 2012). The fact that the 
EPS-25 was sensitive to changes in illness understanding and 
HRQoL, corroborate the usefulness of this scale in clinical and 
research settings of patients with FNS.  
Limitations 
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The high attrition rate is a regrettable limitation of this 
study. As is often the case with postal-questionnaire designs, a 
significant proportion of data were lost by patients’ failure to 
return the follow-up questionnaires. Another limitation is the 
lack of control group or a pre-treatment monitoring period 
demonstrating a lack of spontaneous improvements in emotion 
processing. Although spontaneous clinical improvements may 
be considered unlikely in view of the chronicity of the 
functional disorders treated in this study (mean duration of 5.8 
years (SD = 10.8)), these limitations introduce the possibility 
that any improvements in emotion processing, HRQoL, and 
clinical symptomology could simply reflect regression to the 
mean. Furthermore, mechanism or direction of therapeutic 
change cannot be inferred. Although we only found an age 
difference between the patient groups completing and not 
completing BAPIT, the generalizability of our study findings is 
diminished by the fact that older patients were more likely to 
complete treatment than younger ones. This age disparity in 
therapy completion resonates with earlier studies noting a 
greater probability of older patients engaging in specialist 
psychotherapy for FNS (Howlett, Grunewald, Khan, & Reuber, 
2007). In view of the lack of a control group and the relatively 
high attrition rates in this study, the influence of BAPIT on 
emotion processing requires further clarification. While the 
delivery of BAPIT by a single, highly-trained and experienced 
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therapist (SH) means that there was a low risk of deviation 
from the therapeutic approach (Hobson, 1985; Howlett & 
Reuber, 2009), the absence of treatment data generated by other 
therapists also limits the generalizability of the findings 
presented here.   
 The fact that not all patients who contributed follow-up 
data had completed therapy and that these patients were 
retained in the analysis should be considered a strength of this 
study. The inclusion of these patients in our analysis should 
mean that the findings of our study come closer to the sort of 
effects on emotion processing BAPIT might achieve in real-life 
rather than research settings.  
We were also able to exclude some other biases. 
Patients with NEAD and those with other FNS were matched 
on key demographic variables irrespective of FNS semiology, 
minimising the risks of bias associated with analysing a small 
and heterogeneous population as whole. Consecutive 
recruitment of participants from two sites further reduced risk 
of bias introduced by patient selection. 
Conclusions 
In this prospective, uncontrolled study of patients with 
FNS we provide preliminary evidence that emotion processing 
improves following a course of BAPIT, with simultaneous 
improvements in HRQoL and illness understanding. 
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Improvements in emotion processing correlated with a 
reduction in psychological distress as well as an improved 
mental HRQoL. We also conclude that the EPS-25 shows 
promise as a tool for the investigation of emotion processing 
deficits in patients with FNS. Future research should aim to 
replicate these preliminary findings in controlled studies with 
larger sample sizes.  
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Figure 1 – Flowchart of patient attrition
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Table 1 
Pre- and post-intervention EPS-25 total and subscale scores. 
Note. EPS-25 = Emotion Processing Scale-25. N = 44. 
 
 
Pre-intervention Post-intervention 
EPS-25 scores M SD M SD 
Suppression 5.43 2.58 4.69 2.83 
Unprocessed emotion 5.56 2.86 4.72 2.73 
Unregulated emotion 4.40 2.34 4.10 2.38 
Avoidance 5.07 2.29 4.53 2.28 
Impoverished emotional 
experience 4.33 2.64 3.64 2.55 
Total 4.96 2.26 4.33 2.31 
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demographic and therapy characteristics between patients with NEAD (n = 
32) and patients with ‘other FNS’ (n = 12). 
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*significant at adjusted   value HolmBonferroni correction. CI = confidence interval; 
 = lower limit;  = upper limit. CORE10 = Core Outcome in Routine Evaluation10, 
BIPQ= Brief Illness Perceptions Questionnaire, PHQ15= Patient Health Questionnaire 15, 
MH= Mental Health 	
cale, PH= Physical Health 	
cale

 
 Completers 
 
Noncompleters 
 
   95% CI 
Measure 
  
 
  
 
 
 
 
 

EP25 5.33 2.10 4.68 2.28 41 .96 .36 2.03 0.66 
PHQ15 13.75 5.35 14.63 5.52 35 .47 .64 2.78 4.52 
CORE 10 19.82 9.20 18.00 9.94 41 .60 54 7.96 4.10 
BIPQ 53.52 10.50 60.50 11.30 31 1.80 .08 .38 14.26 
MH 39.72 9.94 40.72 10.70 37 .30 .80 5.90 7.67 
PH 36.60 11.80 35.88 11.34 37 .15 .86 7.44 7.75 
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